Managing ESG Risk in Healthcare

Managing ESG Risk in Healthcare

Anuj A. Shah & Rob Larson • October 12, 2023
Anuj A. Shah & Rob Larson • October 12, 2023

Share

In the healthcare sector, the industry’s core mission revolves around enhancing and preserving lives, which can lead organizations to encounter a multifaceted array of Environmental, Social, and Governance (ESG) challenges. While these challenges are diverse and extend beyond the scope of this introduction, it's essential to identify, comprehend, and effectively manage them within a strategic ESG due diligence framework.

 

By taking a proactive approach to addressing ESG risks, organizations can ensure the delivery of equitable care, safeguarding of patient data, adherence to ethical business practices, and promotion of inclusivity in clinical trials. This comprehensive strategy not only ensures compliance but may also generate substantial value in a critical sector.

Identifying ESG Risks 

Within the healthcare industry, numerous pivotal ESG risks have been discerned; each serving as a fundamental catalyst in molding the future industry landscape. These risks form the core of our ESG due diligence framework and facilitate a comprehensive evaluation specific to an individual asset. Below, we delve into a select few key ESG risks within the domain:

Access to Care

Organizations delivering care or manufacturing medicines are under pressure to offer equitable access to care. They face reputational risks if they ignore the impact on groups of patients who are unequally afforded access to care. Ensuring access to quality healthcare for all is not only an ethical imperative but also a strategic necessity.

Patient Data Security

Patient data security is a direct risk for organizations that handle or protect patient data, including those involved in developing precision medicine. Safeguarding patient information is paramount not only to comply with regulations but also to maintain trust and confidence in healthcare services.

Business Ethics

Fee-for-service reimbursement models may incentivize health organizations to deliver more care than is medically necessary. This exposes them to regulatory and public scrutiny if ethical business practices are abused. Upholding the highest ethical standards in healthcare delivery is vital for maintaining public trust. 

Diversity & Inclusion in Clinical Trials

Companies developing medicines face growing public pressure to include a diverse and representative patient mix in clinical research trials. Ensuring diversity in clinical trials not only enhances the validity of research but also contributes to addressing healthcare disparities among different demographic groups.

ESG Due Diligence Process 

Stax’s ESG due diligence process involves a thorough assessment of material ESG risks across industries. We go beyond identification and provide strategic recommendations on how to track, monitor, and minimize risks during the ownership period. By implementing recommendations, organizations can ensure they are on the right path to meeting asset-specific ESG goals and responsibilities.


By proactively addressing ESG risks, organizations in the healthcare sector can enhance their reputations, strengthen patient trust, and contribute to the overall well-being of society. As the healthcare landscape evolves, it will become increasingly essential for organizations to embed ESG strategies into their operations, ensuring both patients and the healthcare ecosystem as a whole benefit. 

Image of Anuj A. Shah

Managing Director | ESG & Impact Advisory

Image of Rob Larson

Director | Healthcare

Read More

Featured by MicroGrid: How President Trump’s China Tariffs Could Undermine Distributed Energy Gains
April 23, 2025
Phil Dunne was featured by MicroGrid to share his thoughts on the Trump administration's tariffs on China and how they could impact the US energy and EV markets. Read the full feature here.
Stax Recognized by Consulting Magazine for Mentorship and Enrichment Program
April 22, 2025
Stax was recently honored by Consulting Magazine at the Rising Star Awards in Chicago for its innovative approach to talent development. Read about the award ceremony here.
Darren Buskirk Featured on Management Consulted's Podcast
April 22, 2025
Discover what makes Stax a standout in the consulting world as Managing Director Darren Buskirk shares insights on firm culture, career growth, and private equity work. Learn more here.
How Destination Management Drives Value from Strategy to Execution
By David Lindsay April 21, 2025
As demand for in-person corporate events rebounds, David Lindsay explores how DMCs are positioned to scale through advisory services, expansion, and adjacent event types. Learn more.
Stax Provides Sell-side Support to Koozie Group on its Acquisition by Garyline​
April 17, 2025
Stax congratulates Koozie Group, a leading US-based manufacturer, decorator, and supplier of promotional products, on its recent acquisition by Garyline. Learn more about the deal here.
How Leading Teams Are Growing Through Disruption
By Peter Rodrigues-Renon April 16, 2025
Management teams have operated in a generally benign environment. Now, as tariffs cause global disruptions, Peter Rodrigues-Renon shares how teams can still create value. Read more.
Show More